Skip to main content
. 2012 Jun;1823(6):1068–1081. doi: 10.1016/j.bbamcr.2012.03.002

Table 1.

[125I]PYY binding data for Y receptor-sfGFP and BiFC HEK293 cell lines.

Cell line PYY
NPY
GTPγS
pKi Bmax
(pmol mg− 1)
pKi pIC50 Inhibition
(1 μM, %)
sfGFP:
Y1 9.50 ± 0.23 1.5 ± 0.7 9.75 ± 0.16 9.01 ± 0.18 68.6 ± 6.7
Y16A 9.22 ± 0.09 2.3 ± 0.1 9.69 ± 0.04 8.80 ± 0.21 72.9 ± 7.0
Y2 10.76 ± 0.09 2.2 ± 0.3 10.39 ± 0.17 8.81 ± 0.14 69.2 ± 5.4
Y2H155P 10.57 ± 0.05 2.1 ± 0.2 9.91 ± 0.27 8.72 ± 0.15 46.9 ± 10.2



BiFC:
Y1 A1 9.45 ± 0.19 0.7 ± 0.2 9.58 ± 0.07 8.62 ± 0.26 68.5 ± 13.9
Y1 A2 9.54 ± 0.06 0.9 ± 0.4 9.70 ± 0.13 8.54 ± 0.16 66.7 ± 7.0
Y1 A2Δ 9.44 ± 0.08 1.1 ± 0.3 9.76 ± 0.16 8.49 ± 0.02 54.9 ± 7.0
Y16A A1 9.30 ± 0.13 1.6 ± 0.2 9.76 ± 0.11 8.67 ± 0.12 69.4 ± 5.8
Y16A A2 9.48 ± 0.09 1.1 ± 0.3 9.73 ± 0.09 8.63 ± 0.02 78.2 ± 2.1

Data are presented as mean ± s.e.m. from 2 to 6 (typically 3) membrane competition binding experiments, using either 16 pM (Y1 receptor) or 10 pM (Y2 receptor) [125I]PYY as the radiolabel. Y1 A2Δ represents the Y1 receptor BiFC cell line incorporating the β-arrestin2 ΔLIEFD deletion mutant.